Cyclic Adenosine Monophosphate Response Element-binding Protein Transcriptionally Regulates CHCHD2 Associated with the Molecular Pathogenesis of Hepatocellular Carcinoma

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2015 Jan 28

PMID 25625293

Citations 13

Authors

Rui Song

Biao Yang

Xuesong Gao

Jinqian Zhang

Lei Sun

Peng Wang

Yixing Meng

Qi Wang

Shunai Liu

Jun Cheng

Affiliations

Soon will be listed here.

Abstract

The function of the novel cell migration‑promoting factor, coiled‑coil‑helix‑coiled‑coil‑helix domain containing 2 (CHCHD2) in liver cancer remains to be elucidated. The aim of the present study was to elucidate the role of CHCHD2 in liver carcinogenesis. Immunohistochemistry was performed on patients with hepatocellular carcinoma (HCC) and suppression subtractive hybridization (SSH) was used for screening differentially expressed genes in the HepG2 cell cDNA library. Chronic hepatitis C virus (HCV) infection frequently leads to liver cancer. The HCV NS2 protein is a hydrophobic transmembrane protein that is associated with certain cellular proteins. Detailed characterization of the nonstructural protein 2 (NS2) of the HCV was performed with respect to its role in transregulatory activity in the HepG2 cell lines. A gel electrophoresis mobility shift assay and a chromatin immunoprecipitation assay were used to confirm the presence of cyclic adenosine monophosphate response element‑binding protein (CREB), a transcriptional factor, which specifically interacts with the CHCHD2 promoter. CHCHD2 was highly expressed in the HCC specimens and was consistent with tumor markers of HCC. CHCHD2 was identified by SSH in the HepG2 cells. NS2 upregulated the expression of CHCHD2 by monitoring its promoter activities. The promoter of CHCHD2 contained 350 bp between nucleotides ‑257 and +93 and was positively regulated by CREB. In conclusion, the results of the present study indicated that CHCHD2 may be a novel biomarker for HCC and that CREB is important in the transcriptional activation of CHCHD2 by HCV NS2.

Citing Articles

Clinical chorioamnionitis at term is characterized by changes in the plasma concentration of CHCHD2/MNRR1, a mitochondrial protein.

Bosco M, Romero R, Gallo D, Suksai M, Gotsch F, Jung E J Matern Fetal Neonatal Med. 2023; 36(2):2222333.

PMID: 37349086 PMC: 10445405. DOI: 10.1080/14767058.2023.2222333.

Evidence for the participation of CHCHD2/MNRR1, a mitochondrial protein, in spontaneous labor at term and in preterm labor with intra-amniotic infection.

Bosco M, Romero R, Gallo D, Suksai M, Gotsch F, Jung E J Matern Fetal Neonatal Med. 2023; 36(1):2183088.

PMID: 36941246 PMC: 10352953. DOI: 10.1080/14767058.2023.2183088.

Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling.

Li Y, Xiu W, Xu J, Chen X, Wang G, Duan J JCI Insight. 2022; 7(23).

PMID: 36477358 PMC: 9746920. DOI: 10.1172/jci.insight.162402.

CHCHD2 Regulates Mitochondrial Function and Apoptosis of Ectopic Endometrial Stromal Cells in the Pathogenesis of Endometriosis.

Ren Y, Wang X, Guo J, Wang D, Li X, Cheng X Reprod Sci. 2022; 29(8):2152-2164.

PMID: 35157262 DOI: 10.1007/s43032-021-00831-9.

CHCHD2: The Power House's Potential Prognostic Factor for Cancer?.

Gundamaraju R, Lu W, Manikam R Front Cell Dev Biol. 2021; 8:620816.

PMID: 33537311 PMC: 7849849. DOI: 10.3389/fcell.2020.620816.

References

Ravnskjaer K, Kester H, Liu Y, Zhang X, Lee D, Yates 3rd J . Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J. 2007; 26(12):2880-9. PMC: 1894761. DOI: 10.1038/sj.emboj.7601715. View

Santolini E, Pacini L, Fipaldini C, Migliaccio G, Monica N . The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol. 1995; 69(12):7461-71. PMC: 189684. DOI: 10.1128/JVI.69.12.7461-7471.1995. View

Nayak R, Kearns M, Spielman R, Cheung V . Coexpression network based on natural variation in human gene expression reveals gene interactions and functions. Genome Res. 2009; 19(11):1953-62. PMC: 2775589. DOI: 10.1101/gr.097600.109. View

Dentzer T, Lorenz I, Evans M, Rice C . Determinants of the hepatitis C virus nonstructural protein 2 protease domain required for production of infectious virus. J Virol. 2009; 83(24):12702-13. PMC: 2786863. DOI: 10.1128/JVI.01184-09. View

Seo M, Lee W, Suk K . Identification of novel cell migration-promoting genes by a functional genetic screen. FASEB J. 2009; 24(2):464-78. DOI: 10.1096/fj.09-137562. View

Papatheodoridis G, Hadziyannis E, Tsochatzis E, Georgiou A, Kafiri G, Tiniakos D . Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease. J Clin Gastroenterol. 2009; 44(4):e87-95. DOI: 10.1097/MCG.0b013e3181c0945a. View

Cavallaro G . Genome-wide analysis of eukaryotic twin CX9C proteins. Mol Biosyst. 2010; 6(12):2459-70. DOI: 10.1039/c0mb00058b. View

Kannan R, Hensley L, Evers L, Lemon S, McGivern D . Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis. J Virol. 2011; 85(16):7989-8001. PMC: 3147967. DOI: 10.1128/JVI.00280-11. View

Montminy M, Brindle P, Arias J, Ferreri K, Armstrong R . Regulation of somatostatin gene transcription by cyclic adenosine monophosphate. Metabolism. 1996; 45(8 Suppl 1):4-7. DOI: 10.1016/s0026-0495(96)90068-2. View

10.

Lohmann V, Koch J, Bartenschlager R . Processing pathways of the hepatitis C virus proteins. J Hepatol. 1996; 24(2 Suppl):11-9. View

11.

Jin C, Myers A, Tzagoloff A . Cloning and characterization of MRP10, a yeast gene coding for a mitochondrial ribosomal protein. Curr Genet. 1997; 31(3):228-34. DOI: 10.1007/s002940050199. View

12.

Lin C, Lin C, Tan G, Chen W, Dee A, Chan W . The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Am J Pathol. 1997; 150(5):1745-56. PMC: 1858226. View

13.

Flint M, Thomas J, Maidens C, Shotton C, Levy S, Barclay W . Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J Virol. 1999; 73(8):6782-90. PMC: 112763. DOI: 10.1128/JVI.73.8.6782-6790.1999. View

14.

Yanai I, Benjamin H, Shmoish M, Chalifa-Caspi V, Shklar M, Ophir R . Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics. 2004; 21(5):650-9. DOI: 10.1093/bioinformatics/bti042. View

15.

Citterio C, Jones H, Pacheco-Rodriguez G, Islam A, Moss J, Vaughan M . Effect of protein kinase A on accumulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) in HepG2 cell nuclei. Proc Natl Acad Sci U S A. 2006; 103(8):2683-8. PMC: 1413798. DOI: 10.1073/pnas.0510571103. View

16.

Welbourn S, Pause A . The hepatitis C virus NS2/3 protease. Curr Issues Mol Biol. 2007; 9(1):63-9. View

17.

Shaywitz A, Greenberg M . CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 2000; 68:821-61. DOI: 10.1146/annurev.biochem.68.1.821. View

18.

Schaak S, Cayla C, Lymperopoulos A, Flordellis C, Cussac D, Denis C . Transcriptional down-regulation of the human alpha2C-adrenergic receptor by cAMP. Mol Pharmacol. 2000; 58(4):821-7. DOI: 10.1124/mol.58.4.821. View

19.

DAVIES S, Reddy H, Caivano M, Cohen P . Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000; 351(Pt 1):95-105. PMC: 1221339. DOI: 10.1042/0264-6021:3510095. View

20.

Mayr B, Montminy M . Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001; 2(8):599-609. DOI: 10.1038/35085068. View